Several studies have demonstrated that dysregulation of EAAT3 expression or function can lead to various neurological disorders, including Alzheimer's disease, Parkinson's disease, depression, and schizophrenia.40, 41. The gene discussed is SLC1A1; the disease is Parkinson disease.